CAS No. 910463-68-2, Semaglutide API

The Supply Chain Status in China

As of August 20, 2024, there are 226 potential suppliers manufacturing Semaglutide API (CAS No. 910463-68-2), including 186 traders, 40 factories and 29 labs, among which:

- The 25th percentile has an average registered capital of 1 million CNY;

- The 50th percentile has an average registerd capital of 3 million CNY;

-  The 75th percentile has an average registered capital of 8 million CNY.

Feeling overwhelmed? Contact Unibest if you need us to quality-check other sources to strengthen your supply chain or to find a tailored solution for your specific procurement request.

Read more about how Unibest select API sources here.

This manufacturer we recommend strictly follows GMP standard, and has 32 laboratories, 5 API production lines, and 6 injection production line. The Semaglutide API source is produced from fermentation.

In 2023, the PFS & Cartridge injection line was inspected by US FDA. And the Semaglutide API has been put into tablets production in Laos.